Skip to content

HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY)

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519107-10-00
Enrollment
104
Registered
2025-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

transthyretin cardiac amyloidosis

Interventions

None listed

Sponsors

Universita' Degli Studi Di Genova
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Italy

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026